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1. Introduction 
Pregnancy bears a great challenge to the immune system: simultaneously, immune cells 
have to protect the reproductive tract against imminent infections, while the developing 
conceptus has to be tolerated. To face this problem, a distinct composition of immune cells 
has to be present in the decidualized endometrium (Gomez-Lopez, Guilbert et al., 2010). The 
predominant subsets amongst those represent uterine natural killer cells (uNK cells) and 
cells of the monocyte/macrophage lineage like monocytes, macrophages and dendritic cells 
(DC) (Loke and King, 1995). Among the latter ones, DC as antigen-presenting cells (APC) 
are forming an important subgroup (Steinman, 2003).  
DC represent a highly adaptive cell type, which can either be transformed into an 
immunostimulatory phenotype after exposure to inflammatory or infectious signals or into 
a tolerogenic phenotype preventing T cell activation when located in an adequate anti-
inflammatory microenvironment. Establishing contact with invading microorganisms or 
cells, DC acquire their antigens and process them into antigenic peptides in the context of 
MHC class I and class II molecules as ligands for antigen-specific T cell receptors. This 
action is accompanied by migration of DC to secondary lymphoid organs. Here, the 
processed antigens are presented together with co-stimulatory molecules like CD40, CD80 
and CD86 as well as CD83 and MHC molecules (Inaba, Metlay et al., 1990;Steinman, 2003) to 
select and activate naive T cells (Sallusto and Lanzavecchia, 1999).  
Apart from antigens, DC differentiation and maturation is considerably influenced by 
cytokines, hormones and other soluble factors. Lacking infectious/danger- signals or 
localiezed in a distinct anti-inflammatory micromilieu (e.g. TGF beta, IL-10), a specific 
phenotype of DC is generated which prevents T cell activation and which is supposed to 
protect the semi-allogenic fetus (Rutella, Bonanno et al., 2006). 
In human endometrium only a small number of fully matured DC are detected (Rieger, 
Honig et al., 2004). Thereby, the amount of mature, CD83+ DC is generally low in both 
pregnant and non-pregnant endometrium with a slight peak in late secretory phase 
endometrium. During pregnancy, a distinct DC subtype expressing CD14, CD68, HLA-DR 
and DC-SIGN is found in increased levels in decidua (Bonifaz, Bonnyay et al., 
2002;Kammerer, Eggert et al., 2003). These DC, presumably an intertype between immature 
DC (iDC) and macrophages, are supposed to represent a “pro-fetal” tolerogenic population 
which is able to induce a TH2 pre-dominant state (Miyazaki, Tsuda et al., 2003) and to 
suppress the activation of T cells (Kammerer, Eggert et al., 2003).  
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There is evidence that female sex hormones contribute to the modulation of decidual 
immune cells into tolerogenic subtypes (for review see: (Kyurkchiev, Ivanova-Todorova et 
al., 2010) and especially can impact on DC (Segerer, Muller et al., 2009). Thereby, the 
“micromilieu” determines if the captured antigens are presented in a tolerogenic or immune 
activating way resulting also in different phenotypes of DC. In the following, we will 
highlight the impact of the characteristic pregnancy hormones on DC and their potent 
implication on the development of a tolerogenic subtype of DC. 
2. hCG 
Human chorionic gonadotropin (hCG) is a heterodimeric hormone of the glycoprotein 
hormone family and is composed by two subunits linked in a non-covalent way. While the 
alpha subunit does not differ from the other glycoprotein hormones, the beta subunit of 
hCG represents the biggest one of the glycoprotein hormones holding a large glycosylated 
domain which refers to its high stability. hCG represents the very early hormonal factor of 
pregnancy already produced by the trophoblast layer of the blastocyst before implantation 
(Bonduelle, Dodd et al., 1988;Lopata and Hay, 1989) and after implantation by the 
syncytiotrophoblast in increasing amounts (Hoshina, Boothby et al., 1985). The production of 
hCG reaches a peak between the 10th and 11th week of gestation and thereafter declines to a 
lower but constant level throughout pregnancy. Preventing luteolysis of the corpus luteum 
and stimulating the production of progesterone (Keay, Vatish et al., 2004), hCG represents 
the essential factor to protect and to promote early pregnancy. Despite of these direct effects, 
hCG can also act as a paracrine factor modulating the proliferation of myometrial smooth 
muscle cells (Horiuchi, Nikaido et al., 2000;Kornyei, Lei et al., 1993) and increasing 
endometrial angiogenesis (Berndt, Blacher et al., 2009).  
There is also evidence that hCG contributes to maternal tolerance of the developing conceptus 
by influencing the surrounding immune cells. Thus, experiments on uNK cells revealed that 
hCG acts as a regulator of uNK cell proliferation (Kane, Kelly et al., 2009). Despite of this direct 
effect on uNK cell proliferation, hCG can facilitate the adequate establishment and 
maintenance of pregnancy by inducing the secretion factors which promote angiogeneis by 
uNK cells and thus could even support placentation (Lash, Schiessl et al., 2006).  
Investigations on DC demonstrated hCG receptors to be constitutively expressed by these 
cells which allows a direct activation of DC via hCG (Yoshimura, Inaba et al., 2003). 
Experiments on mouse DC revealed that hCG acts in an immunregulatory way by 
increasing the production of immunosuppressive factors like Interleukin-10 (IL-10) by DC 
and by reducing antigen-specific T-cell proliferation (Wan, Versnel et al., 2008). In humans, 
hCG was also able to significantly decrease T-cell stimulatory capacity of DC (Huck, Steck et 
al., 2005). In contrast, the phenotype of hCG-treated DC ressembeled that of matured DC 
expressing co-stimulatory molecules  like CD 40, CD83 and CD 86 (Segerer, Muller et al., 
2009). Thus, hCG seems to be able to induce a tolerogenic subtype of DC even though co-
stimulatory molecules of the mature subtype were expressed.  
3. Estrogen 
Estrogen receptors (ER) alpha and beta (ER ┙/┚) are widely expressed in human 
endometrium but also in most immune cells (Lindzey, Wetsel et al., 1998). Thereby, they are 
localized in different cellular compartments. The cytoplasmatic and membrane associated 
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receptors confer to specific intracellular signaling pathways promoting genomic and non-
genomic effects. Gene transcription and regulation is also mediated by nuclear ER acting as 
transcription factors and thus regulating long-term effects (Tamrazi, Carlson et al., 
2002;Biswas, Singh et al., 2005). Recently, another estrogen receptor, GPR30, which 
represents an intracellular transmembrane G protein-coupled receptor was detected 
(Revankar, Cimino et al., 2005). This receptor is proposed to initiate rapid non-genomic 
signaling effects and was found to be expressed in human endometrium throughout 
menstrual cycle and in early pregnancy  decidua (Kolkova, Noskova et al., 2010). 
B and T lymphocytes were detected to be specific targets of estradiol (Peeva and Zouali, 
2005;Nalbandian, Paharkova-Vatchkova et al., 2005;Nalbandian and Kovats, 2005;Smithson, 
Couse et al., 1998).  Thereby, estrogen was able to modulate B lymphopoiesis and the 
production of immunoglobulins (Ig) where effects were mediated via ER┙ (Erlandsson, 
Jonsson et al., 2003). T cell function was found to be modulated by estradiol changing the 
cytokine profile (Karpuzoglu and Zouali, 2011;Pernis, 2007;Salem, 2004).  
Regarding DC, estradiol effects were mediated via ER┙ and ┚, both of which are expressed 
in DC. So far, the intracellular G-protein receptor GPR 30 has not been described in DC. 
Even though estradiol promotes the differentiation of DC (Paharkova-Vatchkova, 
Maldonado et al., 2004;Segerer, Muller et al., 2009) towards an immunostimulatory 
phenotype, expressing co-stimulatory molecules like CD40, CD83 and CD86, T-cell priming 
was significantly impaired in the presence of estradiol (Segerer, Muller et al., 2009). In 
addition, investigations of the effects of E2 on murine spleen CD11c-positive dendritic cells 
revealed an increased stimulatory capacity of DCs and an elevated expression of the anti-
inflammatory cytokines like IL-10 (Yang, Hu et al., 2006).  
In autoimmune diseases, estrogens seem to have conflicting effects on immune cells. While a 
reduction of disease activity was seen during pregnancy in multiple sclerosis, it was 
reported that systemic lupus erythematodes (SLE) could frequently flare up during 
pregnancy and remit with menopause (Petri, Howard et al., 1991).  
It could be speculated, that the effect of estrogen on DC participates in the flare up of SLE 
during pregnancy: DC generated from monocytes which were isolated from patients 
suffering from SLE exhibited a matured, pro-inflammatory phenotype, expressing co-
stimulatory molecules. In addition, these SLE-DC were very effective in activating T-cells 
(Ding, Mehta et al., 2006). Perhaps, estrogen could even accelerate the maturation-process of 
SLE-DC and thus promote disease during ongoing pregnancy. 
4. Progesterone 
During the menstrual cycle, progesterone is produced by granulosa cells and the corpus 
luteum (Bachelot and Binart, 2005). In pregnancy, the corpus luteum is rescued 4-5 weeks 
after implantation. At that time, placental progesterone production becames sufficient to 
maintain pregnancy (Csapo and Pulkkinen, 1978). Several studies revealed that 
progesterone acts in an immunosuppressive way (Stites and Siiteri, 1983;Miyaura and Iwata, 
2002b). Analysing the effects of progesterone on T lymphocytes, a direct and indirect 
inhibition of TH1 cell development was detected (Miyaura and Iwata, 2002a). DC cultured 
under the influence of progesterone changed their phenotype into an immunostimulatory 
maturated phenotype expressing co-stimulatory molecules (Ivanova, Kyurkchiev et al., 
2005;Segerer, Muller et al., 2009). In contrast to effects seen for hCG and estradiol, the 
capacity of DC to stimulate T-cell proliferation was not significantly altered (Segerer, Muller 
et al., 2009). However, progesterone had profound effects on rat mDC by suppressing the 
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production of pro-inflammatory cytokines like tumor necrosis factor alpha (TNF) and 
interleukin 1beta (IL-1) as well as by inhibiting the DC-stimulated proliferation of T-cells 
(Butts, Shukair et al., 2007). Thus, even though the expression of co-stimulatory molecules 
and T-cell stimulatory capacity was not affected progesterone seems to modulate immune 
responses by changing the cytokine secretion prolife. 
5. Activin A and inhibin A 
Activin A represents a distinct growth factor and member of the TGF beta superfamily 
(Chang, Brown et al., 2002) which is composed by two activin A subunits. Its counterpart 
inhibin A is formed by a dimer consisting of an activin  subunit and a structurally different 
 subunit (Phillips, Jones et al., 2005). Initially, the function of these glycoprotein hormones 
was defined as feedback factors regulating the release of the follicle-stimulating hormone 
(FSH) (Tong, Wallace et al., 2003). Later, it was observed that activin A and inhibin A are 
endowed by diverse functions acting as cytokines in an autocrine or paracrine manner, too. 
Thus, activin A was detected to be involved in inflammatory responses (Jones, de Kretser et 
al., 2004) and acting as a chemoattractant for monocytes (Eramaa, Hurme et al., 1992;Shao, 
Frigon, Jr. et al., 1992). 
During pregnancy, activin A and inhibin A are locally produced by human placenta, 
decidua and fetal membranes resulting in serum levels in the low ng/ml range peaking at 
10 weeks of gestation (Lockwood, Ledger et al., 1997). Both glycoprotein hormones seem to 
have some impact on implantation and early embryo development (Birdsall, Ledger et al., 
1997;Muttukrishna, Jauniaux et al., 2004;Jones, Salamonsen et al., 2002). Furthermore, they 
have been found to be useful diagnostic markers for pregnancy success. While decreasing 
activin A levels indicated both an ongoing miscarriage or ectopic pregnancy (Florio, Severi 
et al., 2007), decreasing inhibin A levels were used as a specific marker to reveal preclinical 
abortions (Muttukrishna, Jauniaux et al., 2004;Prakash, Laird et al., 2005). 
Previous studies revealed that activin A is able to modulate immune responses via type I 
and II activin receptors on DC (Robson, Phillips et al., 2008). Even though the expression of 
co-stimulatory molecules was not significantly affected neither by activin A nor inhibin A, 
both glycoprotein hormones were able to decrease the T-cell stimulatory capacity of DC. 
Thus, we propose that activin A and inhibin A are distinct modulating factors that could 
promote the generation of tolerance-inducing DC by affecting their T-cell stimulatory 
capacity (Segerer, Muller et al., 2008) . 
 
 DC phenotype 
T-cell stimulatory 
capacity 
cytokines 
hCG 
immunostimulatory 
(CD40 |, CD83 |, CD86 |) ‾ IL-10 | 
estrogen 
immunostimulatory 
(CD40 |, CD83 |, CD86 |) ‾ IL-10 | 
progesterone 
immunostimulatory 
(CD40 |, CD83 |, CD86 |) 
‾ (in rats) 
} (in humans) 
TNF-┙ ‾, IL-1 ┚ ‾ 
(in rats) 
activin A and 
inhibin A 
immunostimulatory 
(CD40 |, CD83 |, CD86 |) ‾ 
no significant 
effects 
Table 1. 
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6. Summary 
During pregnancy, the levels of the glycoprotein hormones activin A and inhibin A as well as 
female sex hormones (hCG, estradiol, progesterone) are substantially elevated in parallel with 
increased occurrence of cells of the monocyte/macrophage lineage like DC in the decidua. In 
vitro experiments revealed that all of them can induce a tolerogenic subtype of DC even 
though effects were found on different levels (reduction of the expression of co-stimulatory 
molecules, reduction of T-cell stimulation, tolerogenic cytokine-profile). Thus, this distinct 
mixture of hormonal factors seems to be indispensable to support the development of 
tolerance-inducing DC which could play a key role in the acceptance of the fetus. 
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